本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Kymera Therapeutics, Inc.

44.91
+0.01000.02%
盤前44.910.00000.00%08:00 EDT
成交量:106.17萬
成交額:4,741.21萬
市值:31.51億
市盈率:-14.43
高:45.33
開:45.30
低:43.66
收:44.90
資料載入中...
2025/02/27

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/27

重要事件披露

Form 8-K - Current report
2025/01/14

重要事件披露

Form 8-K - Current report
2025/01/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/15

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/08

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/31

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/10/31

重要事件披露

Form 8-K - Current report
2024/09/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/22

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/20

重要事件披露

Form 8-K - Current report
2024/08/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/07

重要事件披露

Form 8-K - Current report
2024/07/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities